Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-03-26
2004-02-03
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S783000, C514S893000, C514S894000, C514S885000, C424S725000, C424S773000, C424S774000, C424S779000
Reexamination Certificate
active
06686375
ABSTRACT:
FIELD OF INVENTION
The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant
Cryptolepis Buchanani
and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.
BACKGROUND AND PRIOR ART REFERENCES
Cryptolepis buchanani
Roem. & Schult. (Family Asclepiadaceae) is distributed throughout hot deciduous forests of India and holds a very prestigious position in Ayurveda.
It is a very useful plant because of its multiple uses as a traditional medicine, such as anti-diarrheal, anti-bacterial, anti-ulcerative, anti-inflammatory, blood purifier and for lactation in women [Bhakuni, D. S., Dhar, M. L., Dhar, M. M., Dhawan, B. N., and Mehrotra, B. N.,.
Ind. J. Expt. Biol.,
7: 250-262 (1969), Bhav Prakash, Commentary on Bhav Prakash Nighantu edited by C. K. Chunekar, Chowkhamba Vidya Bhavan, Varanasi 4
th
edition: 427 (1969)].
Ethanolic extract of roots and stem show hypotensive, central nervous system depressant and antiamphetaminic activity [Joshi, M. C., Patel, M. B. and Mehta, P.
J. Bull. Med. Ethno. Bot. Res.,
1: 8-24 (1980)].
Ethanolic extract of aerial parts of plant shows diuretic activity [Dhawan, B. N., Patnaik, G. K., Rastogi, R. P., Singh, K. K. and Tandon, J. S.,
Ind. J. Expt. Biol.,
15: 208-219 (1977)].
Root bark is used in rheumatic pains [Mudgal, V. and Pal, D. C., Bull.
Bot. Surv. Ind.,
22: 59-62 (1980)].
Stem constituents are alkaloids and triterpenes, leaves constituents are &agr; and &bgr; amyrin ( Asolkar, L. V., Kakkar, K. K. and Chakre, O. J., Glossary of Indian Medicinal Plants with active principles, part-1, A-K., 1965-1981(1992)] and cryptolepine—the methyl-quinolanol alkaloid of
cryptolepis sanguinolenta.
Pyridine alkaloid, buchanine [Dutta, Sunil K, Sharma, Batuk N, Sharma, Priya V.
Phytochemistry
17, 2047(1978)] and a cardenolide cryptosin, 7,8-Epoxy-3,11,14-trihydroxy-12-Oxocard 20 (22)-enolide [Venkateshwara R; Narendra N; Viswametra M. A; Vaidyanathan C. S.;
Phytochemistry
28, 1203 (1989)] are the major chemical constituent of the plant. Apart from these chemical constituents cryptanoside —A to D and germenicol [Purshothman K. K; Saradha V; Connolly J. D; Rycroft D. S,
Rev. Latinomer Quim.,
19, 28 (1988)], 1,3,6-trinicotinoyl-&bgr;-D-glucopyranoside and 1,3,6-trinicotinoyl-&agr;-D-glucopyranoside, n -trinicontanol, n-triactonoic acid, &bgr;-amyrin and &bgr;-sitosterol glucoside [Dutta S. K; Sharma B. N; Sharma P. V.,
Phytochemistry,
17, 2047 (1978), Dutta S. K; Sharma B. N, Sharma P. V; (1980)
Phytochemistry,
19, 1278 (1980)].
The alcoholic extract of the root shows the presence of sterols, reducing sugars and traces of glycosides and exhibited antiplatelet effects in vitro in humans, rabbits and rats. In rats, it exhibited ADP-aggregation in vitro with delayed onset and prolonged action. It exhibited an indirect fibrinolytic action in the rat possibly by causing the release of plasminogen activators from the vascular endothelium [Oyekan, A. O., Botting, J. H. and Noamesi, B. K., General Pharmacol., 19: 223-227 (1988)].
Liver has a pivotal role in regulation of physiological processes. Toxic chemicals and infections mainly cause liver diseases. Hepatocyte alterations of various origins result in acute and chronic dysfunctions, which may be lethal [Decker K. and Keppler D. Rev.
Physiol. Biochem. Pharmacol.,
71, 79-106 (1974)].
Liver disorders are still the major hazard both in urban and rural population. Despite scientific advances in our understanding in the management of liver disorders and the leads provided by traditional system of medicine, no specific treatment for liver ailments is available except a few herbal preparations, WHO, Regional Office Manila, 1993.; [Subeamoniam and Pushpangadan,
Indian Journal of Pharmacology,
31,166-175 (1999)].
It is emphasized that hepatotoxin that causes acute hepatitis should have close resemblance with the viral hepatitis, clinically, biochemically and histologically. In many instances drug induced hepatitis proves indistinguishable from viral hepatitis. Chemically induced hepatic injury for experimental studies should be severe enough to cause death or to modify hepatic function. The mechanism of acute hepatic injury depends upon the chemical compound and the species of animals used. Many chemicals produce parenchymal damage (cytotoxic injury), arrest bile flow and cause jaundice. The damage may be acquired or toxicological phenonmenon, therapeutic misadventure or induced experimentally. Drugs also cause chronic hepatic diseases such as hepatitis, fatty liver, cirrhosis, and several vascular lesions of the liver.
It is the role of hepatoprotective agents to interfere with these pathological processes by blocking their evolution and helping recovery by preventing hepatocytes degeneration, necrosis, steatosis and inflammation, stimulate regeneration processes, and inhibit fibrosis which leads to cirrhosis and death [Doreswamy, R., Sharma, D.,
Indian Drugs,
32, 139-144 (1995)], Kumar et al, Cell injury and adaptation. In: “Basic Pathology”, 5
th
Edn. Prime Books (pvt.) Ltd., Banglore, India. 1992, pp. 3-24.
Acute hepatitis closely resembling viral hepatitis clinically, biochemically and histologically, can be produced by chemicals and drugs in humans and experimental animals, [AL-Tuwaijiri A. et al Heptology, 51: 107-113 (1981); Decker K. and Keppler D.
Rev Physiol. Biochem. Pharmacol.,
71, 79-106 (1974); Kumar et al, Cell injury and adaptation. In: “Basic Pathology”, 5
th
Edn. Prime Books (Pvt.) Ltd., Banglore, India. 1992, pp. 3-24].
OBJECT OF THE PRESENT INVENTION
The main object of the present invention is to develop a composition comprising extract from plant
Cryptolepis buchanani
and/or its fractions.
Another main object of the present invention is to develop a composition comprising plant
Cryptolepis buchanani
having hepatoprotective activity.
Yet another object of the present invention is to develop a method of producing a composition comprising extract from plant
Cryptolepis buchanani
and/or its fractions having hepatoprotection activity.
Still another object of the present invention is to develop a method of treating a subject including animals and/or humans for hepatoprotection, using a composition comprising extract from plant
Cryptolepis buchanani
and/or its fractions. Still another object of the present invention is to develop a composition extract from plant
Cryptolepis buchanani
and/or its fractions with better hepatoprotective activity as compared to commercially available hepatoprotective drugs.
SUMMARY OF THE PRESENT INVENTION
The present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant
Cryptolepis Buchanani
and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.
DETAILED DESCRIPTION OF THE PRESENT INVENTION
Accordingly, the present invention relates to a composition useful for hepatoprotection, said composition comprising polar extract of plant
Cryptolepis Buchanani
and/or fractions of the said extract, and optionally pharmaceutically acceptable additives and a method of producing said composition and also a method of treating a subject using said composition.
In an embodiment of the present invention, a composition useful for hepatoprotection, said composition comprising effective amount of polar solvent extract (A001) from plant
Cryptolepis buchanani
and optionally pharmaceutically acceptable additives.
In another embodiment of the present invention, wherein said additives are selected from a group of nutrients comprising proteins, carbohydrates, sugar, talc, magnesium stearate, cellulose, calcium carbonate, starc
Chandan Bal Krishan
Jaggi Bupinder Singh
Kapahi Bal Krishnan
Kumar Ashwani
Manhas Lila Ram
Council of Scientific and Industrial Research
Krass Frederick
Morgan & Finnegan , LLP
Ostrup Clinton
LandOfFree
Composition useful as hepatoprotectants comprising extract... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition useful as hepatoprotectants comprising extract..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition useful as hepatoprotectants comprising extract... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3323856